Dolvis Bio Pharma Private Limited, a active private limited company, was established on 27 March 2012 in Manimajra, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232CH2012PTC033674. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Piyush Garg (Additional Director), Sanjay Kumar Garg (Director). Past directors included Jeet Kumar Jain, Anita Garg. It holds ₹6.50 M open charges and ₹7.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Scf 265, Second Floor Motor Market, Manimajra, Chandigarh, 160101.
U24232CH2012PTC033674
033674
27 March 2012
₹0.20 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Dolvis Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Garg | Additional Director | 01 Feb 2025 | Current |
| Sanjay Kumar Garg | Director | 27 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dolvis Bio Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.33% increase. The company also saw a slight decrease in profitability, with a 1.66% decrease in profit. The company's net worth Soared by an impressive increase of 24.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dolvis Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹7,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Others | ₹1.50 M | Open |
| 29 Mar 2024 | Others | ₹5.00 M | Open |
| 06 Aug 2015 | Hdfc Bank Limited | ₹7.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dolvis Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dolvis Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolvis Bio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Piyush Garg was appointed as a Additional Director was appointed as a Additional Director on 01 Feb 2025 & has been associated with this company since 9 months 29 days . was documented.
Progress on Dolvis Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 1.50 M with Charge ID 100964094 was registered on 24 Jul 2024. was documented.
The activity Dolvis Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100889221 was registered on 29 Mar 2024. was documented.
A charge registered on 06 Aug 2015 via Charge ID 10603533 with Hdfc Bank Limited was fully satisfied on 14 Mar 2024. was recorded as a recent event.
The CIN of Dolvis Bio Pharma Private Limited is U24232CH2012PTC033674.
Dolvis Bio Pharma Private Limited is headquartered at Scf 265, Second Floor Motor Market, Manimajra, Chandigarh, 160101.
Dolvis Bio Pharma Private Limited was incorporated on 27 March 2012.
The current directors of Dolvis Bio Pharma Private Limited are
The primary industry of Dolvis Bio Pharma Private Limited is Trade.
Dolvis Bio Pharma Private Limited is unlisted.
The authorized capital of Dolvis Bio Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dolvis Bio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX